Haynes and Boone Represents Alliqua in $29 Million Transaction
January, 2018 - Dallas, Texas
Haynes and Boone, LLP represented Alliqua BioMedical, Inc. in a $29 million asset purchase agreement with Celularity, Inc., a transaction announced Jan. 5.
New York-based Partners Rick Werner and Greg Kramer and Associate Patrick Horan represented Alliqua, a regenerative technologies company with locations in Yardley, Pennsylvania, Langhorne, Pennsylvania and Eden Prairie, Minnesota.
The agreement, which is subject to stockholder approval, calls for Celularity to acquire all of the property, assets and rights relating to Alliquas advanced biologic wound care business - including Biovance amniotic membrane allograft and Interfyl Human Connective Tissue Matrix - and the company's UltraMist Therapy System and other therapeutic ultrasound platform products for an aggregate cash consideration of $29 million.
Alliqua's announcement said the agreement includes all intellectual property and all license, marketing, development and supply agreements related to the businesses.
